共 50 条
- [3] Comparison of Cost-Effectiveness of Oral Rapamycin Plus Bare-Metal Stents Versus First Generation of Drug-Eluting Stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 Trial) AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (05): : 815 - 821
- [5] Percutaneous Coronary Intervention With Bare Metal Stents and Oral Sirolimus Has Comparable Safety and Efficacy to Treatment With Drug Eluting Stents but With Significant Lower Cost: 31 Months Cost Saving and Clinical Events Analysis From the Randomized, Controlled ORAR III (Oral Rapamycin in Argentina) Study CIRCULATION, 2009, 120 (18) : S967 - S967
- [6] Percutaneous Coronary Intervention with Bare Metal Stents and Oral Sirolimus has Comparable Safety and Efficacy to Treatment with Drug Eluting Stents but with Significant Cost Saving : Long Term Follow Up Results From the Randomized, Controlled ORAR III (Oral Rapamycin in Argentina) Study CIRCULATION, 2008, 118 (18) : S1051 - S1051
- [10] Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention OPEN HEART, 2016, 3 (02):